Fast Respiratory Virus detection test appproved

A new test developed at McMaster University and just approved by U.S. Food and Drug Administration (FDA) provides fast diagnosis and detection of the most common respiratory viruses, including flu and the common cold. The test was developed by McMaster virologist Dr. James Mahony, together with Luminex Molecular Diagnostics (formerly known as TM Biosciences).

The xTAG™ Respiratory Viral Panel detects most of the common respiratory viruses in just a few hours. Previous methods required multiple diagnostic tests and could take several days for a thorough diagnosis. Because xTAG™ RVP is fast and reliable physicians will be able to provide speedy and appropriate treatment. This should help to prevent inappropriate antibiotic use which has helped in the creation of "superbugs."

FDA approval means that U.S. laboratories can use the test to detect 12 viruses and viral subtypes. These are responsible for over 85% of respiratory viral infections. The list includes rhinovirus, influenza A, influenza A-H1, influenza A-H3, influenza B, Adenovirus, respiratory syncytial virus (RSV) A and B, metapneumovirus, and parainfluenza 1, 2, and 3.

The test is also certified to detect 20 viruses and viral subtypes in Europe,including SARS and influenza A H5 (the subtype associated with avian influenza). Luminex aim to get the test certified for use in Canada.